Skip to main content
. 2022 Jan 27;21(1):305–312. doi: 10.1007/s40200-022-00973-w

Table 1.

Demographic data and clinical variables of patients undergoing treatment with debridement and maggot therapy

Parameters Debridement group (N, %) Larval therapy group (N, %) p-value*
Age (years) 45–50 9 (22%) 7 (17%) 0.575
50–55 6 (15%) 8 (20%) 0.559
55–60 17 (43%) 20 (50%) 0.533
60–65 8 (20%) 5 (13%) 0.402
Education High school Diploma and sub-diploma 29 (72%) 25 (62%) 0.345
Associate Degree 1 (3%) 4 (10%) 0.207
Bachelor 9 (22%) 8 (20%) 0.827
Masters 1 (3%) 3 (8%) 0.330
Sex Male 22 (55%) 21 (52%) 0.789
Female 18 (45%) 19 (48%)
Smoking history Yes 25 (62%) 35 (87%) 0.011
No 15 (38%) 5 (13%)
History of drug abuse Yes 9 (22%) 12 (30%) 0.418
No 31 (78%) 28 (70%)
Wound depth Grade 2 10 (25%) 9 (22%) 0.753
Grade 3 30 (75%) 31 (78%)
Diabetes Yes 40 (100%) 40 (100%) 1.0
No 0 (0%) 0 (0%)
Cardiac disease Yes 19 (48%) 18 (45%) 0.789
No 21 (52%) 22 (55%)
Hypertension Yes 7 (17%) 11 (27%) 0.283
No 33 (83%) 29 (73%)

*Chi-squared test by MedCalc software